WinstonDunnMD

Gastroenterology • Kansas City, KS

Hepatology & Liver Transplantation

Assistant Professor, Internal Medicine, University Kansas School of Medicine

Join to view full profile

Dr. Dunn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dunn's full profile

Already have an account?

Office
3901 Rainbow Blvd
# Wescoe
Kansas City, KS 66160
Phone+1 507-284-2511

Fax+1 913-588-3975

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2009 - 2010
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2006 - 2009
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003

Certifications & Licensure

CA State Medical License 2005 - Present
KS State Medical License 2010 - 2025
MO State Medical License 2021 - 2025
MN State Medical License 2009 - 2011
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis.
Alvi Husni Islam, Luis Antonio Díaz, Francisco Idalsoaga, Leonardo Guizzetti, Rokhsana Mortuza
Hepatology Communications. 2024-11-01
2 citations
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.
Winston Dunn, Yanming Li, Ashwani K Singal, Douglas A Simonetto, Luis A Díaz
Hepatology. 2024-11-01
4 citations
Racial and ethnic disparities in the natural history of alcohol-associated liver disease in the United States.
Gustavo Ayares, Luis Antonio Díaz, Eduardo Fuentes-López, Francisco Idalsoaga, Thomas G Cotter
Liver International. 2024-10-01

Press Mentions

Gene Predicts Recovery from Decompensated HCV CirrhosisApril 10th, 2019
Study: Genetic Markers May Predict Which HCV, Cirrhosis Patients Improve with TreatmentMay 6th, 2017